Randy Strong

Person

Leads the University of Texas Health Science Center at San Antonio site for the ITP and is a pharmacologist.

Mentioned in 4 videos

Videos Mentioning Randy Strong

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

#148 - Richard Miller, M.D., Ph.D.: The gold standard for testing longevity drugs: the ITP

Peter Attia MD

A collaborator in the ITP, leading one of the three testing labs at UT San Antonio.

222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.

222 ‒ How nutrition impacts longevity | Matt Kaeberlein, Ph.D.

Peter Attia MD

One of the PIs on the Interventions Testing Program, who recognized the instability of Rapamycin in food and developed an encapsulated form (e-rapa) for the mouse lifespan experiment.

281 ‒ Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program

281 ‒ Longevity drugs, aging biomarkers, and updated findings from the Interventions Testing Program

Peter Attia MD

Leads the University of Texas Health Science Center at San Antonio site for the ITP and is a pharmacologist.

216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.

216 - Metabolomics, NAD+, and cancer metabolism | Josh Rabinowitz, M.D., Ph.D.

Peter Attia MD

A researcher associated with the ITP program at NIH.